Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Shares Outstanding (Weighted Average) (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Shares Outstanding (Weighted Average) readings, the most recent being $68.0 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 3.15% to $68.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $68.0 million, a 3.15% increase, with the full-year FY2025 number at $68.0 million, up 3.15% from a year prior.
  • Shares Outstanding (Weighted Average) hit $68.0 million in Q4 2025 for Tandem Diabetes Care, up from $193788.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $68.0 million in Q4 2025 to a low of $193788.0 in Q3 2023.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $64.1 million (2022), compared with a mean of $45.5 million.
  • The widest YoY moves for Shares Outstanding (Weighted Average): up 34499.67% in 2025, down 99.7% in 2025.
  • Tandem Diabetes Care's Shares Outstanding (Weighted Average) stood at $63.0 million in 2021, then increased by 1.82% to $64.1 million in 2022, then increased by 1.28% to $65.0 million in 2023, then increased by 1.49% to $65.9 million in 2024, then grew by 3.15% to $68.0 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $68.0 million (Q4 2025), $193788.0 (Q3 2025), and $67.0 million (Q2 2025) per Business Quant data.